BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18428050)

  • 1. Detection of BRAF V600E mutation by pyrosequencing.
    Tan YH; Liu Y; Eu KW; Ang PW; Li WQ; Salto-Tellez M; Iacopetta B; Soong R
    Pathology; 2008 Apr; 40(3):295-8. PubMed ID: 18428050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas.
    Jo YS; Huang S; Kim YJ; Lee IS; Kim SS; Kim JR; Oh T; Moon Y; An S; Ro HK; Kim JM; Shong M
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):139-44. PubMed ID: 18462259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
    Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
    Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
    Domingo E; Laiho P; Ollikainen M; Pinto M; Wang L; French AJ; Westra J; Frebourg T; Espín E; Armengol M; Hamelin R; Yamamoto H; Hofstra RM; Seruca R; Lindblom A; Peltomäki P; Thibodeau SN; Aaltonen LA; Schwartz S
    J Med Genet; 2004 Sep; 41(9):664-8. PubMed ID: 15342696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection.
    Ibrahem S; Seth R; O'Sullivan B; Fadhil W; Taniere P; Ilyas M
    Int J Exp Pathol; 2010 Dec; 91(6):500-5. PubMed ID: 21199003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma.
    Anderson S; Bloom KJ; Vallera DU; Rueschoff J; Meldrum C; Schilling R; Kovach B; Lee JR; Ochoa P; Langland R; Halait H; Lawrence HJ; Dugan MC
    Arch Pathol Lab Med; 2012 Nov; 136(11):1385-91. PubMed ID: 22332713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
    Ilie MI; Long-Mira E; Hofman V; Mouroux J; Vignaud JM; Gauchotte G; Begueret H; Merlio JP; Emile JF; Hébuterne X; Hofman P
    Pathology; 2014 Jun; 46(4):311-5. PubMed ID: 24798160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.
    Benlloch S; Payá A; Alenda C; Bessa X; Andreu M; Jover R; Castells A; Llor X; Aranda FI; Massutí B
    J Mol Diagn; 2006 Nov; 8(5):540-3. PubMed ID: 17065421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test.
    Hang JF; Li AF; Chang SC; Liang WY
    Histopathology; 2016 Jul; 69(1):54-62. PubMed ID: 26588428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
    Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
    Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study.
    Taniguchi H; Okamoto W; Muro K; Akagi K; Hara H; Nishina T; Kajiwara T; Denda T; Hironaka S; Kudo T; Satoh T; Yamanaka T; Abe Y; Fukushima Y; Yoshino T
    Neoplasia; 2018 Dec; 20(12):1219-1226. PubMed ID: 30412858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular platforms utilized to detect BRAF V600E mutation in melanoma.
    Curry JL; Torres-Cabala CA; Tetzlaff MT; Bowman C; Prieto VG
    Semin Cutan Med Surg; 2012 Dec; 31(4):267-73. PubMed ID: 23174497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and application of the hot spot BRAF gene mutation (p.V600E) in the diagnostic strategy for Hereditary Nonpolyposis Colorectal Cancer.
    Kadiyska TK; Konstantinova DV; Atanasov VR; Kremensky IM; Mitev VI
    Cancer Detect Prev; 2007; 31(3):254-6. PubMed ID: 17566669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
    Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.
    Colomba E; Hélias-Rodzewicz Z; Von Deimling A; Marin C; Terrones N; Pechaud D; Surel S; Côté JF; Peschaud F; Capper D; Blons H; Zimmermann U; Clerici T; Saiag P; Emile JF
    J Mol Diagn; 2013 Jan; 15(1):94-100. PubMed ID: 23159108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity PCR method for detecting BRAF V600E mutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles.
    Chen D; Huang JF; Xia H; Duan GJ; Chuai ZR; Yang Z; Fu WL; Huang Q
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2477-87. PubMed ID: 24500755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors.
    Hayashi Y; Sasaki H; Takeshita S; Nishikawa R; Nishikawa H; Arakawa A; Yamashita Y; Takahashi S; Sugiura-Ogasawara M
    Oncol Rep; 2014 Nov; 32(5):1815-9. PubMed ID: 25174456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis.
    Dimmler A; Geddert H; Werner M; Faller G
    Virchows Arch; 2017 Apr; 470(4):429-435. PubMed ID: 28220299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHPLC is a highly sensitive and rapid screening method to detect BRAF(V600E) mutation in papillary thyroid carcinoma.
    Kim TE; Jung ES; Jung CK; Bae JS; Kim SN; Kim GS; Lee HN; Kang CS; Choi YJ
    Exp Mol Pathol; 2013 Feb; 94(1):203-9. PubMed ID: 22691412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing.
    Yeo MK; Jung MK; Lee SY; Lee YM; Hur GM; Kim JM
    J Clin Pathol; 2017 Mar; 70(3):260-265. PubMed ID: 27543599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.